R. Shimoyama

发表

Effect of Carbamazepine on the Single Oral Dose Pharmacokinetics of Alprazolam

K. Otani, S. Kaneko, T. Kondo, 1998, Neuropsychopharmacology.

Monitoring of phenytoin in human breast milk, maternal plasma and cord blood plasma by solid-phase extraction and liquid chromatography.

Yoshiharu Saito, K. Sugawara, T. Ohkubo, 1998, Journal of pharmaceutical and biomedical analysis.

Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method.

K. Sugawara, T. Ohkubo, R. Shimoyama, 1999, Biomedical chromatography : BMC.

Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography

K. Sugawara, T. Ohkubo, R. Shimoyama, 2000, Annals of clinical biochemistry.

CHARACTERISTICS OF INTERACTION BETWEEN BARBITURATE DERIVATIVES AND VARIOUS SORBENTS ON LIQUID CHROMATOGRAPHY AND DETERMINATION OF PHENOBARBITAL IN JAPANESEHUMAN BREAST MILK

K. Sugawara, T. Ohkubo, R. Shimoyama, 2000 .

High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma.

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

High performance liquid chromatographic determination of levomepromazine in human breast milk and serum using solid phase extraction.

K. Sugawara, T. Ohkubo, R. Shimoyama, 1993, Biomedical chromatography : BMC.

Determination of chlorpromazine in human breast milk and serum by high-performance liquid chromatography.

K. Sugawara, T. Ohkubo, R. Shimoyama, 1993, Journal of chromatography.

Measurement of haloperidol in human breast milk by high-performance liquid chromatography.

K. Sugawara, T. Ohkubo, R. Shimoyama, 1992, Journal of pharmaceutical sciences.

Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients

K. Otani, S. Kaneko, N. Yasui, 1997, International clinical psychopharmacology.

Effects of the CYP 2D6 Genotype and Cigarette Smoking on the Steady‐State Plasma Concentrations of Fluvoxamine and Its Major Metabolite Fluvoxamino Acid in Japanese Depressed Patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Therapeutic drug monitoring.

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

K. Otani, H. Higuchi, Keizo Yoshida, 2003, Psychopharmacology.